Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Been noticing a lot of chatter about cannabis stocks lately, and honestly, it's making me wonder if people are setting themselves up for another disappointment. Let me break down what's actually happening here.
So here's the thing - if you invested in cannabis stocks over the past five years, you got absolutely wrecked. The S&P 500 basically doubled, right? Meanwhile, the AdvisorShares Pure US Cannabis ETF tanked 77%. That's not a bad year, that's a catastrophic collapse. Tilray and other major names in the space have been absolutely demolished.
But now there's this renewed buzz. The Trump administration is apparently considering rescheduling marijuana from Schedule I (same category as heroin and LSD) down to Schedule III. And suddenly everyone's asking - will marijuana stocks ever recover? Is this finally the moment?
I get why people are excited. If federal rescheduling actually happens, it would be massive for the industry. Right now, cannabis companies can't operate across state lines legally, which makes scaling incredibly expensive and inefficient. A company like Tilray is literally based in Canada because it can't properly operate in the U.S. market. If that changed, these businesses could actually expand nationally and access the U.S. market properly.
Rescheduling to Schedule III would also let cannabis companies deduct normal business expenses on their taxes - something they can't do now under Section 280E. That alone would dramatically improve profitability for multi-state operators.
Here's where it gets interesting though. Even after the recent rally, these stocks are trading at dirt cheap valuations. Tilray's market cap is only about $1.8 billion now, down from nearly $17 billion back in early 2021. It's trading at 1.8x trailing sales and 1.2x price-to-book. That's genuinely cheap if you believe in the thesis.
But - and this is a big but - we've been here before. The government has talked about cannabis reform multiple times over the years. Bills have been proposed, excitement builds, and then... nothing happens. Will marijuana stocks ever recover? That depends entirely on whether reform actually materializes, and that's far from guaranteed.
The reality is, rescheduling could still be years away. Maybe it happens, maybe it doesn't. If you're thinking about cannabis stocks, you need to be comfortable with the idea that this could take a very long time to play out, if it happens at all. These are high-risk, speculative positions for patient investors only.
For most people? Honestly, I'd say wait and see. Don't chase the hype just because there's some positive momentum. The cannabis sector has burned too many investors to jump in without a clear catalyst that's actually locked in. Will marijuana stocks ever recover their former glory? Possibly. But timing is everything, and right now we're still in the "maybe" phase.